Emily Lythell

Emily is a qualified UK and European Patent Attorney working as part of the life sciences team in Manchester. She works with clients across Europe, the US, and Singapore, including universities and start-ups right through to large multinationals. Emily combines deep scientific knowledge with practical IP strategies, enabling clients to protect and commercialise their innovations.

Emily has a strong academic background in structural biology, biochemistry and biophysics. Her expertise is particularly centred on the study of enzyme structure and activity, a subject she explored in depth during her doctoral research at the University of Bristol, which included a research placement at a large pharmaceutical firm. Her experience extends through to computational chemistry, and has authored a number of publications focused on dynamic modelling of enzyme structure and mechanism.

She leverages this comprehensive knowledge across an array of fields, including cell and gene therapies, the development and optimisation of antibodies, biotechnology innovations, and advancements in agriculture. Her ability to translate core scientific principles into practical applications enables her to contribute meaningfully to a variety of projects, supporting clients from diverse sectors in tackling complex life sciences challenges.

An area of particular interest is the field of antimicrobial resistance, which was the focus of her PhD research. She is enthusiastic about advancing this medically important area, recognising both its vital role in healthcare and the unique challenges it presents in translation and funding. Emily is dedicated to supporting progress and innovation in antimicrobial resistance, and believes that greater awareness can help unlock new opportunities for impactful solutions.

Areas of Expertise

• Structural biology
• Biochemistry
• Enzyme structure and activity
• Molecular biology
• Microbiology and antibiotic resistance mechanisms

Background

Emily has a PhD in Cellular and Molecular Medicine from the University of Bristol, and a first-class Master’s degree in Biochemistry from the University of Birmingham.

Emily joined Mewburn Ellis in 2022 and qualified as a Chartered UK and European patent attorney in 2025.